The Univeristy of Texas M.D. Anderson Cancer Center
The Univeristy of Texas M.D. Anderson Cancer Center received $13.7M in federal prime contract obligations in the 12 months ending Oct 5, 2026, up 6.2% from $12.9M the year before, and $67.6M since FY2022. Its largest customer is the Department of Health and Human Services.
See 6 contracts ending in the next 18 months ↓Contractor details
- Unique Entity ID (UEI)
- S3GMKS8ELA16
- CAGE code
- 0KD38
- Doing business as
- MD Anderson Cancer Center
- Headquarters
- Houston, TX
- Business size
- Other Than Small Business
- Parent company
- University of Texas System (UEI X5NKD2NFF2V3)
As recorded on this UEI's most recent prime contract action in USAspending.gov. Confirm current registration and certifications in SAM.gov.
Obligations by fiscal year
Net prime contract obligations by federal fiscal year.
Markets where it ranks top 10
Agency and NAICS markets where this UEI is one of the ten largest primes in the latest 12 months.
Top agencies
Funding agencies ranked by obligations since FY2022.
| Funding agency | Latest 12 mo | Since FY2022 |
|---|---|---|
| Department of Health and Human Services | $13.3M | $65.7M |
| Department of Veterans Affairs | $389K | $1.8M |
| Department of Defense | $0 | $3K |
Top NAICS codes
Industry codes agencies recorded on this contractor's awards, since FY2022.
| NAICS | Industry | Latest 12 mo | Since FY2022 |
|---|---|---|---|
| 621991 | Blood and Organ Banks | $9.1M | $45.6M |
| 541714 | Research and Development in Biotechnology (except Nanobiotechnology) | $1.4M | $9.5M |
| 541940 | Veterinary Services | $2.4M | $8.5M |
| 541990 | All Other Professional, Scientific, and Technical Services | $387K | $2.0M |
| 112990 | All Other Animal Production | $524K | $1.5M |
| 541720 | Research and Development in the Social Sciences and Humanities | −$21K | $303K |
What it sells
Product and service codes (PSC) on this contractor's awards, since FY2022.
| PSC | Description | Since FY2022 |
|---|---|---|
| Q508 | Medical- Hematology | $45.6M |
| R499 | Support- professional: Other | $8.5M |
| AN12 | Health R&D services; Health Care services; Applied Research | $7.8M |
| AJ11 | General Science and Technology R&D services; General Science and technology; Basic Research | $1.9M |
| Q527 | Medical- Nuclear Medicine | $1.8M |
| 8820 | Live Animals, NOT Raised for Food | $1.7M |
Contracts ending in the next 18 months
This contractor's largest awards whose current period of performance ends soon. Options and extensions often move these dates.
| Award | Agency | Obligated | Current end |
|---|---|---|---|
| 75N91023F00001 | Department of Health and Human Services FURTHER DEVELOPMENT OF IPSC-BASED VACCINE FOR COLON CANCER PREVENTION | $1.3M | Dec 25, 2026 |
| 75N91023F00003 | Department of Health and Human Services TARGETING THE A2B ADENOSINE RECEPTOR FOR IMMUNOPREVENTION OF PANCREATIC CANCER | $1.3M | Mar 14, 2027 |
| 75N91022F00001 | Department of Health and Human Services PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS-- TARGETING THE PARP PATHWAY FOR THE PREVENTION OF BREAST CANCER | $1.1M | May 31, 2027 |
| 75N98026C00052 | Department of Health and Human Services OPERATION AND MAINTENANCE OF THE CHIMPANZEE CARE CENTER (CCC) | $1.6M | Aug 31, 2027 |
| 36C24524P0903 | Department of Veterans Affairs MED PHYSICS PEER REVIEW SERVICES | $1.1M | Sep 29, 2027 |
| 75N91025F00001 | Department of Health and Human Services PROJECT TITLE: LOW-DOSE ERLOTINIB AND MESALAMINE FOR PREVENTION OF COLITIS-ASSOCIATED COLORECTAL CANCER (CAC) | $1.3M | Mar 24, 2028 |
Recent awards
This contractor's newest prime contract awards, most recent first.
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| 75N98026C00052 | Department of Health and Human Services OPERATION AND MAINTENANCE OF THE CHIMPANZEE CARE CENTER (CCC) | $1.6M | Aug 31, 2026 |
| 75F40126P00275 | Department of Health and Human Services BORDETELLA-FREE BABOONS FOR PERTUSSIS INFECTION AND VACCINATION STUDIES | $369K | Aug 31, 2026 |
| 75F40126C00055 | Department of Health and Human Services BAA FY26C1FP7 MD ANDERSON ONCOLOGY CENTER FOR EXCELLENCE (OCE), EVALUATING BAYESIAN EFFECTIVE SAMPLE SIZE AND DECISION CRITERIA FOR PEDIATRIC AND RARE DISEASE TRIALS | $752K | Aug 6, 2026 |
| 75F40126P00158 | Department of Health and Human Services BORDETELLA-FREE BABOON STUDY | $206K | Aug 5, 2026 |
| 36C25726P0378 | Department of Veterans Affairs RATIFICATION FOR CALIBRATION SERVICES | $3K | Apr 30, 2026 |
| 75N91025F00001 | Department of Health and Human Services PROJECT TITLE: LOW-DOSE ERLOTINIB AND MESALAMINE FOR PREVENTION OF COLITIS-ASSOCIATED COLORECTAL CANCER (CAC) | $692K | Sep 22, 2025 |
| 75F40125C00075 | Department of Health and Human Services BAA-MD ANDERSON-STATISTICAL DESIGNS AND CONSIDERATIONS FOR DOSE OPTIMIZATION FY25C1FP6 | $1.1M | Sep 16, 2025 |
| 75N98025F00003 | Department of Health and Human Services V105: NON-HUMAN PRIMATE ACQUISITION | $123K | Sep 16, 2025 |
Other University of Texas System entities
UEIs that report the same ultimate parent in SAM.gov. Ownership records can lag acquisitions.
University of Texas at Austin
$630.1MUniversity of Texas at Austin
$51.4MThe University of Texas Southwestern Medical Center
$45.5MUniversity of Texas Health Science Center of SAN Antonio
$14.8MPrime contracts (award types A–D) from USAspending.gov through Oct 5, 2026. Subcontracts are not included. Net obligations include deobligations and corrections.
Ready to connect your pursuit work?
GovEagle gives BD directors, capture managers, and proposal teams one AI workspace from pipeline through proposal, with CMMC/FedRAMP Certified compliance built in.